SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 4.60 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 3.15 |
| Book Value / Share | 1.02 |
| Price / Book | n/a |
| NCAV ($M) | -12.68 |
| NCAV / Share | -4.11 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.50 |
| Return on Assets (ROA) | -0.26 |
| Return on Equity (ROE) | -1.27 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.58 |
| Current Ratio | 0.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 23.36 |
| Assets | 39.19 |
| Liabilities | 36.04 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 54.03 |
| Operating Income | -10.23 |
| Net Income | -10.59 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -1.08 |
| Cash from Investing | -0.47 |
| Cash from Financing | 3.83 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 684 | 7,473 | 9.15 | |
| 4,808 | 7,845 | 61.29 | |
| 2,418 | 5,509 | 43.89 | |
| 372 | 1,715 | 21.69 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IBIO – iBio, Inc. | ICCC – ImmuCell Corporation |
| IKT – Inhibikase Therapeutics, Inc. | IMMX – Immix Biopharma, Inc. |
| IMNM – Immunome, Inc. |
Financial data and stock pages provided by
Fintel.io